Welcome to LookChem.com Sign In|Join Free

CAS

  • or

207557-34-4

N-(2-aminoethyl)-N-[5-(trifluoromethyl)pyridin-2-yl]amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

207557-34-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 207557-34-4 Structure

  • Basic information

    1. Product Name: N-(2-aminoethyl)-N-[5-(trifluoromethyl)pyridin-2-yl]amine
    2. Synonyms: N-(2-aminoethyl)-N-[5-(trifluoromethyl)pyridin-2-yl]amine
    3. CAS NO:207557-34-4
    4. Molecular Formula: C8H10F3N3
    5. Molecular Weight: 205.1803096
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 207557-34-4.mol
    9. Article Data: 3

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 291.4±40.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.316±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 9.08±0.10(Predicted)
    10. CAS DataBase Reference: N-(2-aminoethyl)-N-[5-(trifluoromethyl)pyridin-2-yl]amine(CAS DataBase Reference)
    11. NIST Chemistry Reference: N-(2-aminoethyl)-N-[5-(trifluoromethyl)pyridin-2-yl]amine(207557-34-4)
    12. EPA Substance Registry System: N-(2-aminoethyl)-N-[5-(trifluoromethyl)pyridin-2-yl]amine(207557-34-4)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 207557-34-4(Hazardous Substances Data)

207557-34-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 207557-34-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,7,5,5 and 7 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 207557-34:
(8*2)+(7*0)+(6*7)+(5*5)+(4*5)+(3*7)+(2*3)+(1*4)=134
134 % 10 = 4
So 207557-34-4 is a valid CAS Registry Number.

207557-34-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name N'-[5-(trifluoromethyl)pyridin-2-yl]ethane-1,2-diamine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:207557-34-4 SDS

207557-34-4Relevant articles and documents

Novel Pyrimidine- And Triazine-Hepcidine Antagonists

-

, (2015/09/30)

The present invention relates to new hepcidin antagonists, pharmaceutical compositions containing them and the use thereof as a drug, in particular for the treatment of iron metabolism disorders such as, in particular, iron deficiency diseases and anaemia, in particular anaemia associated with chronic inflammatory disease (ACD: anaemia of chronic disease and AI: anaemia of inflammation).

Inhibitors of glycogen synthase kinase 3

-

, (2008/06/13)

Novel pyridine and pyrimidine derivatives which selectively inhibit glycogen synthase kinase 3 are provided and methods of preparing these compounds are provided. These compounds are useful in treating certain conditions which may be mediated by glycogen synthase kinase 3.

Inhibitors of glycogen synthase kinase 3

-

, (2008/06/13)

New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 207557-34-4